Добавлены профессиональными переводчиками и компаниями и на основе веб-страниц и открытых баз переводов.
stess), inkluża artrite rewmatojdika, lupus eritematosuż sistemiku, skleroderma, sindrom ta ’ sjögren, u dermatomijositi/ polimijositi.
including rheumatoid arthritis, systemic lupus erythematosus, scleroderma, sjögren’ s syndrome and dermatomyositis/ polymyositis.
dan il- mard awtoimmuni jinkludi artrite rewmatojde, lupus erythematosus sistemiku, skleroderma, is- sindrome ta ’ sjögren jew dermatomijosite/ polimijosite.
these autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus, scleroderma, sjögren's syndrome and dermatomyositis/ polymyositis.
hu rakkomandat li l- għadd taċ- ċelluli bojod tad- dejjem ikun iċċekkjat sabiex wieħed ikun jista ’ jinduna jekk hemmx xi lewkopinja. ikun aħjar jekk fil- fażi inizjali tal- kura u f’ pazjenti b’ indeboliment fil- funzjoni renali, dawk li fl- istess ħin għandhom mard fil - collagen (eż. lupus erythematosus jew skleroderma) u dawk kollha kkurati b’ prodotti mediċinali oħra li jistgħu jikkawża tibdil f’ dak li għandu x’ jaqsam mad- demm (ara sezzjonijiet 4. 5 u 4. 8).
more frequent monitoring is advised in the initial phase of treatment and in patients with impaired renal function, those with concomitant collagen disease (e. g. lupus erythematosus or scleroderma), and all those treated with other medicinal products that can cause changes in the blood picture (see sections 4.5 and 4.8).